[Disparity of the bone marrow involvement in a 5-year-old boy with primary non-Hodgkin's malignant lymphoma of the bone]

Przegl Lek. 1992;49(3):102-3.
[Article in Polish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Asparaginase / administration & dosage
  • Bone Marrow / drug effects
  • Bone Marrow / pathology*
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / pathology*
  • Child, Preschool
  • Daunorubicin / administration & dosage
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / pathology*
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology*
  • Prednisone / administration & dosage
  • Radius / drug effects
  • Radius / pathology*
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Asparaginase
  • Prednisone
  • Daunorubicin

Supplementary concepts

  • PVDA protocol